1. Home
  2. PROP vs MCRB Comparison

PROP vs MCRB Comparison

Compare PROP & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prairie Operating Co.

PROP

Prairie Operating Co.

N/A

Current Price

$0.31

Market Cap

44.9M

Sector

Finance

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$1.46

Market Cap

41.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PROP
MCRB
Founded
2001
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
41.2M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
PROP
MCRB
Price
$0.31
$1.46
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$1.50
★ $17.00
AVG Volume (30 Days)
★ 1.2M
88.3K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 49.06
N/A
EPS
★ N/A
N/A
Revenue
★ $7,939,000.00
$789,000.00
Revenue This Year
$85.81
$1,648.67
Revenue Next Year
$11.47
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 413.59
N/A
52 Week Low
$0.30
$1.30
52 Week High
$2.55
$29.98

Technical Indicators

Market Signals
Indicator
PROP
MCRB
Relative Strength Index (RSI) 36.77 28.78
Support Level N/A N/A
Resistance Level $0.44 $2.26
Average True Range (ATR) 0.05 0.22
MACD -0.01 0.03
Stochastic Oscillator 2.94 20.83

Price Performance

Historical Comparison
PROP
MCRB

About PROP Prairie Operating Co.

Prairie Operating Co is an independent oil and natural gas company focused on the acquisition and development of crude oil, natural gas, and natural gas liquids (NGLs). Its assets and operations are located in the oil region of rural Weld County, Colorado, within the Denver-Julesburg Basin in Colorado (the DJ Basin). The company generates maximum revenue from crude oil sales, and the rest from the sale of natural gas and natural gas liquids.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: